Skip to main content

Postprocedural Assessments and Considerations

  • Chapter
  • First Online:
Anesthesia Management for Electroconvulsive Therapy
  • 815 Accesses

Abstract

Postictal agitation is a frequent complication during the emergence period after ECT. This symptom commonly resolves naturally within 1 h, but a severe or persistent episode requires pharmacological treatment with benzodiazepines or propofol to control the acute situation. Hypoxemia following ECT can also occur in this period, and monitoring of oxygen saturation should be continued until psychomotor function resumes. When desaturation is prolonged, initial pulmonary aspiration of increased saliva or gastric contents is suggested. Patients generally require about 2 h of post-ECT care in the recovery room and adverse symptoms, especially headache, should be noted. Elderly patients have a high risk of fall and should be monitored carefully. Memory disturbance is an important cognitive impairment during and after ECT course and may impair optimal functioning. In some cases, ECT parameters should be modified based on the assessment of cognitive function to minimize this adverse effect. Continuation/maintenance ECT is an effective treatment option for relapse prevention after successful treatment with index ECT and is often performed in an ambulatory setting. The decision to transfer the patient from inpatient to ambulatory ECT requires careful assessment of the treatment response and adverse effects of ECT.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mankad MV, Weiner RD. Adverse effects. In: Mankad MV, Beyer JL, Weiner RD, Krystal AD, editors. Clinical manual of electroconvulsive therapy. Arlington: American Psychiatric Publishing, Inc.; 2010. p. 139–48.

    Google Scholar 

  2. Auriacombe M, Rénéric JP, Usandizaga D, Gomez F, Combourieu I, Tignol J. Post-ECT agitation and plasma lactate concentrations. J ECT. 2000;16:263–7.

    Article  CAS  PubMed  Google Scholar 

  3. Cristancho MA, Alici Y, Augoustides JG, O’Reardon JP. Uncommon but serious complications associated with electroconvulsive therapy: recognition and management for the clinician. Curr Psychiatry Rep. 2008;10:474–80.

    Article  PubMed  Google Scholar 

  4. Kikuchi A, Yasui-Furukori N, Fujii A, Katagai H, Kaneko S. Identification of predictors of post-ictal delirium after electroconvulsive therapy. Psychiatry Clin Neurosci. 2009;63:180–5.

    Article  PubMed  Google Scholar 

  5. Sato M, Hirota K, Shirakami G, Kakuyama M, Tanabe H, Fukuda K. Safety in general anesthesia for ambulatory electroconvulsive therapy. Masui. 2013;62:52–9.

    PubMed  Google Scholar 

  6. Mankad MV, Weiner RD. Anesthetics and other medications. In: Mankad MV, Beyer JL, Weiner RD, Krystal AD, editors. Clinical manual of electroconvulsive therapy. Arlington: American Psychiatric Publishing, Inc.; 2010. p. 81–93.

    Google Scholar 

  7. Augoustides JG, Greenblatt E, Abbas MA, O'Reardon JP, Datto CJ. Clinical approach to agitation after electroconvulsive therapy: a case report and literature review. J ECT. 2002;18:213–7.

    Article  PubMed  Google Scholar 

  8. O'Reardon JP, Takieddine N, Datto CJ, Augoustides JG. Propofol for the management of emergence agitation after electroconvulsive therapy: review of a case series. J ECT. 2006;22:247–52.

    Article  PubMed  Google Scholar 

  9. Tzabazis A, Schmitt HJ, Ihmsen H, Schmidtlein M, Zimmermann R, Wielopolski J, et al. Postictal agitation after electroconvulsive therapy: incidence, severity, and propofol as a treatment option. J ECT. 2013;29:189–95.

    Article  PubMed  Google Scholar 

  10. Mizrak A, Koruk S, Ganidagli S, Bulut M, Oner U. Premedication with dexmedetomidine and midazolam attenuates agitation after electroconvulsive therapy. J Anesth. 2009;23:6–10.

    Article  PubMed  Google Scholar 

  11. O’Brien EM, Rosenquist PB, Kimball JN, Dunn GN, Smith B, Arias LM. Dexmedetomidine and the successful management of electroconvulsive therapy postictal agitation: a case report. J ECT. 2010;26:131–3.

    Article  PubMed  Google Scholar 

  12. Bryson EO, Briggs MC, Pasculli RM, Kellner CH. Treatment-resistant postictal agitation after electroconvulsive therapy (ECT) controlled with dexmedetomidine. J ECT. 2013;29, e18.

    Article  PubMed  Google Scholar 

  13. Vishne T, Amiaz R, Grunhaus L. Promethazine for the treatment of agitation after electroconvulsive therapy: a case series. J ECT. 2005;21:118–21.

    Article  CAS  PubMed  Google Scholar 

  14. Small JG, Milstein V. Lithium interactions: lithium and electroconvulsive therapy. J Clin Psychopharmacol. 1990;10:346–50.

    Article  CAS  PubMed  Google Scholar 

  15. Prudic J. Strategies to minimize cognitive side effects with ECT: aspects of ECT technique. J ECT. 2008;24:46–51.

    Article  PubMed  Google Scholar 

  16. Swartz CM. Electroconvulsive therapy emergence agitation and succinylcholine dose. J Nerv Ment Dis. 1990;178:455–7.

    Article  CAS  PubMed  Google Scholar 

  17. Devanand DP, Sackeim HA. Use of increased anesthetic dose prior to electroconvulsive therapy to prevent postictal excitement. Gen Hosp Psychiatry. 1992;14:345–9.

    Article  CAS  PubMed  Google Scholar 

  18. Reti IM, Krishnan A, Podlisky A, Sharp A, Walker M, Neufeld KJ, et al. Predictors of electroconvulsive therapy postictal delirium. Psychosomatics. 2014;55:272–9.

    Article  PubMed  Google Scholar 

  19. American Psychiatric Association Committee on Electroconvulsive Therapy. The practice of electroconvulsive therapy: Recommendations for treatment, training, and privileging. 2nd ed. Washington, DC: American Psychiatric Association; 2001.

    Google Scholar 

  20. Bailine SH, Petrides G, Doft M, Lui G. Indications for the use of propofol in electroconvulsive therapy. J ECT. 2003;19:129–32.

    Article  PubMed  Google Scholar 

  21. Krystal AD. Managing the ECT seizure. In: Mankad MV, Beyer JL, Weiner RD, Krystal AD, editors. Clinical manual of electroconvulsive therapy. Arlington: American Psychiatric Publishing, Inc.; 2010. p. 149–57.

    Google Scholar 

  22. Avramov MN, Husain MM, White PF. The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy. Anesth Analg. 1995;81:596–602.

    Google Scholar 

  23. Lowenstein DH, Alldredge BK. Status epilepticus. N Engl J Med. 1998;338:970–6.

    Article  CAS  PubMed  Google Scholar 

  24. Saito S. Anesthesia management for electroconvulsive therapy: hemodynamic and respiratory management. J Anesth. 2005;19:142–9.

    Article  PubMed  Google Scholar 

  25. Saito S, Kadoi Y, Nihishara F, Aso C, Goto F. End-tidal carbon dioxide monitoring stabilized hemodynamic changes during ECT. J ECT. 2003;19:26–30.

    Article  PubMed  Google Scholar 

  26. Mayur PM, Shree RS, Gangadhar BN, Subbakrishna DK, Janakiramaiah N, Rao GS. Atropine premedication and the cardiovascular response to electroconvulsive therapy. Br J Anaesth. 1998;81:466–7.

    Article  CAS  PubMed  Google Scholar 

  27. Ding Z, White PF. Anesthesia for electroconvulsive therapy. Anesth Analg. 2002;94:1351–64.

    Article  PubMed  Google Scholar 

  28. Tecoult E, Nathan N. Morbidity in electroconvulsive therapy. Eur J Anaesthesiol. 2001;18:511–8.

    Article  CAS  PubMed  Google Scholar 

  29. McCormick AS, Saunders DA. Oxygen saturation of patients recovering from electroconvulsive therapy. Anaesthesia. 1996;51:702–4.

    Article  CAS  PubMed  Google Scholar 

  30. Wayne SL, O'Donovan CA, McCall WV, Link K. Postictal neurogenic pulmonary edema: experience from an ECT model. Convuls Ther. 1997;13:181–4.

    CAS  PubMed  Google Scholar 

  31. Kurnutala LN, Kamath S, Koyfman S, Yarmush J, SchianodiCola J. Aspiration during electroconvulsive therapy under general anesthesia. J ECT. 2013;29, e68.

    Article  PubMed  Google Scholar 

  32. Burke WJ, Rubin EH, Zorumski CF, Wetzel RD. The safety of ECT in geriatric psychiatry. J Am Geriatr Soc. 1987;35:516–21.

    Article  CAS  PubMed  Google Scholar 

  33. Buisseret P. Acute pulmonary edema following grand mal epilepsy and as a complication of electric shock therapy. Br J Dis Chest. 1982;76:194–5.

    Article  CAS  PubMed  Google Scholar 

  34. Takahashi T, Kinoshita K, Fuke T, Urushihata K, Kawamata T, Yanagisawa S, et al. Acute neurogenic pulmonary edema following electroconvulsive therapy: a case report. Gen Hosp Psychiatry. 2012;34:703.e9–703.e11.

    Google Scholar 

  35. Myers CL, Gopalka A, Glick D, Goldman MB, Dinwiddie SH. A case of negative-pressure pulmonary edema after electroconvulsive therapy. J ECT 2007;23:281–3.

    Google Scholar 

  36. Cochran M, DeBattista C, Schmiesing C, Brock-Utne JG. Negative-pressure pulmonary edema: a potential hazard in patients undergoing ECT. J ECT. 1999;15:168–70.

    Article  CAS  PubMed  Google Scholar 

  37. Weber DL, Ruvolo C, Cashin P. Sudden death following electroconvulsive therapy. N Y State J Med. 1973;73:1000–1.

    CAS  PubMed  Google Scholar 

  38. Mamah D, Lammle M, Isenberg KE. Pulmonary embolism after ECT. J ECT. 2005;21:39–40.

    Article  PubMed  Google Scholar 

  39. Singh G, Wahi S. Pulmonary embolism in the ECT patient: a case report and discussion. Gen Hosp Psychiatry. 2008;30:87–9.

    Article  PubMed  Google Scholar 

  40. Mehta V, Mueller PS, Gonzalez-Arriaza HL, Pankratz VS, Rummans TA. Safety of electroconvulsive therapy in patients receiving long-term warfarin therapy. Mayo Clin Proc. 2004;79:1396–401.

    Article  PubMed  Google Scholar 

  41. Saito S, Kadoi Y, Iriuchijima N, Obata H, Arai K, Morita T, et al. Reduction of cerebral hyperemia with anti-hypertensive medication after electroconvulsive therapy. Can J Anaesth. 2000;47:767–74.

    Article  CAS  PubMed  Google Scholar 

  42. Sundsted KK, Burton MC, Shah R, Lapid MI. Preanesthesia medical evaluation for electroconvulsive therapy: a review of the literature. J ECT. 2014;30:35–42.

    Article  CAS  PubMed  Google Scholar 

  43. MacPherson RD, Loo CK. Cognitive impairment following electroconvulsive therapy – does the choice of anesthetic agent make a difference? J ECT. 2008;24:52–6.

    Article  CAS  PubMed  Google Scholar 

  44. Hooten WM, Rasmussen KG. Effects of general anesthetic agents in adults receiving electroconvulsive therapy: a systematic review. J ECT. 2008;24:208–23.

    Article  CAS  PubMed  Google Scholar 

  45. Rasmussen KG. Propofol for ECT anesthesia a review of the literature. J ECT. 2014;30:210–5.

    Article  CAS  PubMed  Google Scholar 

  46. Irvin SM. Treatment of depression with outpatient electroconvulsive therapy. AORN J. 1997;65:573–82.

    Article  CAS  PubMed  Google Scholar 

  47. Li TC, Shiah IS, Sun CJ, Tzang RF, Huang KC, Lee WK. Mirtazapine relieves post-electroconvulsive therapy headaches and nausea: a case series and review of the literature. J ECT. 2011;27:165–7.

    Article  CAS  PubMed  Google Scholar 

  48. Markowitz JS, Kellner CH, DeVane CL, Beale MD, Folk J, Burns C, et al. Intranasal sumatriptan in post-ECT headache: results of an open-label trial. J ECT. 2001;17:280–3.

    Article  CAS  PubMed  Google Scholar 

  49. Weiner SJ, Ward TN, Ravaris CL. Headache and electroconvulsive therapy. Headache. 1994;34:155–9.

    Article  CAS  PubMed  Google Scholar 

  50. Leung M, Hollander Y, Brown GR. Pretreatment with ibuprofen to prevent electroconvulsive therapy-induced headache. J Clin Psychiatry. 2003;64:551–3.

    Article  CAS  PubMed  Google Scholar 

  51. White PF, Purdue L, Downing M, Thornton L. Intranasal sumatriptan for prevention of post-ECT headaches. Headache. 2006;46:692.

    PubMed  Google Scholar 

  52. Kramer BA, Kadar AG, Clark K. Use of the Neuro-Wrap system for severe post-electroconvulsive therapy headaches. J ECT. 2008;24:152–5.

    Article  PubMed  Google Scholar 

  53. Kramer BA, Kadar AG, Clark K. Transcutaneous acupoint electrical stimulation in preventing and treating nausea and vomiting in patients receiving electroconvulsive therapy. J ECT. 2003;19:194–6.

    Article  PubMed  Google Scholar 

  54. Cattan RA, Barry PP, Mead G, Reefe WE, Gay A, Silverman M. Electroconvulsive therapy in octogenarians. J Am Geriatr Soc. 1990;38:753–8.

    Article  CAS  PubMed  Google Scholar 

  55. van der Wurff FB, Stek ML, Hoogendijk WJ, Beekman AT. The efficacy and safety of ECT in depressed older adults: a literature review. Int J Geriatr Psychiatry. 2003;18:894–904.

    Article  PubMed  Google Scholar 

  56. de Carle AJ, Kohn R. Electroconvulsive therapy and falls in the elderly. J ECT. 2000;16:252–7.

    Article  PubMed  Google Scholar 

  57. Reti IM, Walker M, Pulia K, Gallegos J, Jayaram G, Vaidya P. Safety considerations for outpatient electroconvulsive therapy. J Psychiatr Pract. 2012;18:130–6.

    Article  PubMed  Google Scholar 

  58. Fink M, Abrams R, Bailine S, Jaffe R. Ambulatory electroconvulsive therapy: report of a task force of the association for convulsive therapy. Convuls Ther. 1996;12:42–55.

    CAS  PubMed  Google Scholar 

  59. Awad IT, Chung F. Factors affecting recovery and discharge following ambulatory surgery. Can J Anaesth. 2006;53:858–72.

    Google Scholar 

  60. Semkovska M, McLoughlin DM. Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biol Psychiatry. 2010;68:568–77.

    Article  PubMed  Google Scholar 

  61. Verwijk E, Comijs HC, Kok RM, Spaans HP, Stek ML, Scherder EJ. Neurocognitive effects after brief pulse and ultrabrief pulse unilateral electroconvulsive therapy for major depression: a review. J Affect Disord. 2012;140:233–43.

    Article  PubMed  Google Scholar 

  62. Meeter M, Murre JM, Janssen SM, Birkenhager T, van den Broek WW. Retrograde amnesia after electroconvulsive therapy: a temporary effect? J Affect Disord. 2011;132:216–22.

    Article  PubMed  Google Scholar 

  63. Herrmann LL, Goodwin GM, Ebmeier KP. The cognitive neuropsychology of depression in the elderly. Psychol Med. 2007;37:1693–702.

    Article  PubMed  Google Scholar 

  64. Porter RJ, Douglas K, Knight RG. Monitoring of cognitive effects during a course of electroconvulsive therapy: recommendations for clinical practice. J ECT. 2008;24:25–34.

    Article  PubMed  Google Scholar 

  65. Geretsegger C, Nickel M, Judendorfer B, Rochowanski E, Novak E, Aichhorn W. Propofol and methohexital as anesthetic agents for electroconvulsive therapy: a randomized, double-blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance. J ECT. 2007;23:239–43.

    Article  CAS  PubMed  Google Scholar 

  66. Vaidya PV, Anderson EL, Bobb A, Pulia K, Jayaram G, Reti I. A within-subject comparison of propofol and methohexital anesthesia for electroconvulsive therapy. J ECT. 2012;28:14–9.

    Article  CAS  PubMed  Google Scholar 

  67. Bauer J, Hageman I, Dam H, Báez A, Bolwig T, Roed J, et al. Comparison of propofol and thiopental as anesthetic agents for electroconvulsive therapy: a randomized, blinded comparison of seizure duration, stimulus charge, clinical effect, and cognitive side effects. J ECT. 2009;25:85–90.

    Article  CAS  PubMed  Google Scholar 

  68. Ingram A, Schweitzer I, Ng CH, Saling MM, Savage G. A comparison of propofol and thiopentone use in electroconvulsive therapy: cognitive and efficacy effects. J ECT. 2007;23:158–62.

    Google Scholar 

  69. Sackeim HA, Prudic J, Fuller R, Keilp J, Lavori PW, Olfson M. The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology. 2007;32:244–54.

    Article  PubMed  Google Scholar 

  70. Fazzino TL, Rabinowitz T, Althoff RR, Helzer JE. Monitoring daily affective symptoms and memory function using interactive voice response in outpatients receiving electroconvulsive therapy. J ECT. 2013;29:318–24.

    Article  PubMed  Google Scholar 

  71. Jaffe R, Dubin W, Shoyer B, Roemer R, Sharon D, Lipschutz L. Outpatient electroconvulsive therapy: efficacy and safety. Convuls Ther. 1990;6:231–8.

    PubMed  Google Scholar 

  72. Dew R, McCall WV. Efficiency of outpatient ECT. J ECT. 2004;20:24–5.

    Article  PubMed  Google Scholar 

  73. Trevino K, McClintock SM, Husain MM. A review of continuation electroconvulsive therapy: application, safety, and efficacy. J ECT. 2010;26:186–95.

    Article  PubMed  Google Scholar 

  74. Petrides G, Tobias KG, Kellner CH, Rudorfer MV. Continuation and maintenance electroconvulsive therapy for mood disorders: review of the literature. Neuropsychobiology. 2011;64:129–40.

    Article  PubMed  PubMed Central  Google Scholar 

  75. van Schaik AM, Comijs HC, Sonnenberg CM, Beekman AT, Sienaert P, Stek ML. Efficacy and safety of continuation and maintenance electroconvulsive therapy in depressed elderly patients: a systematic review. Am J Geriatr Psychiatry. 2012;20:5–17.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masami Sato .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Japan

About this chapter

Cite this chapter

Sato, M. (2016). Postprocedural Assessments and Considerations. In: Saito, S. (eds) Anesthesia Management for Electroconvulsive Therapy. Springer, Tokyo. https://doi.org/10.1007/978-4-431-55717-3_6

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-55717-3_6

  • Published:

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-55716-6

  • Online ISBN: 978-4-431-55717-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics